Adileh Ayati
- Organic Chemistry top 2%
- Synthesis and biological activity 15
- Click Chemistry and Applications 9
- Synthesis and Characterization of Heterocyclic Compounds 4
- Quinazolinone synthesis and applications 3
- Synthesis and Biological Evaluation 3
- Toxicology top 5%
-
- Computational Drug Discovery Methods 4
-
- Cholinesterase and Neurodegenerative Diseases 3
- Synthesis of Organic Compounds 3
- Co-authors
- Alireza ForoumadiSaeed EmamiSetareh MoghimiAli AsadipourAbbas ShafieeMaliheh SafaviBehjat PouramiriSomayeh Salarinejad
- Journals
- European Journal of Medicinal Chemistry (6 papers)Frontiers in Chemistry (1 paper)Bioorganic Chemistry (1 paper)
- Partner nations
- IranCyprusSaudi Arabia
In The Last Decade
Adileh Ayati
22 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Organic Chemistry 898
- Toxicology 37
- Computational Theory and Mathematics 127
- Oncology 178
- Molecular Biology 422
Countries citing papers authored by Adileh Ayati
This map shows the geographic impact of Adileh Ayati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adileh Ayati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adileh Ayati more than expected).
Fields of papers citing papers by Adileh Ayati
This network shows the impact of papers produced by Adileh Ayati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adileh Ayati. The network helps show where Adileh Ayati may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adileh Ayati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 6 | |
| 6 | 2021 | 83 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 12 | |
| 10 | A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapybreakdown → | 2020 | 278 |
| 11 | 2019 | 115 | |
| 12 | 2018 | 39 | |
| 13 | 2018 | 41 | |
| 14 | 2016 | 111 | |
| 15 | 2016 | 0 | |
| 16 | Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discoverybreakdown → | 2015 | 372 |
| 17 | 2015 | 3 | |
| 18 | 2013 | 3 | |
| 19 | 2012 | 46 | |
| 20 | 2011 | 53 |
About Adileh Ayati
Adileh Ayati is a scholar working on Organic Chemistry, Pharmacology and Physiology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Synthesis and biological activity (15 papers), Click Chemistry and Applications (9 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers), Computational Drug Discovery Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Synthesis of Organic Compounds (3 papers), Quinazolinone synthesis and applications (3 papers) and Synthesis and Biological Evaluation (3 papers). The work is most often cited by research in Organic Chemistry (898 citations), Toxicology (37 citations) and Computational Theory and Mathematics (127 citations). Adileh Ayati has collaborated with scholars based in Iran, Cyprus and Saudi Arabia. Frequent co-authors include Alireza Foroumadi, Saeed Emami, Setareh Moghimi, Ali Asadipour, Abbas Shafiee, Maliheh Safavi, Behjat Pouramiri, Somayeh Salarinejad, Mahsa Toolabi and Hamid Irannejad. Their work appears in journals such as European Journal of Medicinal Chemistry, Frontiers in Chemistry and Bioorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.